Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins.

MLA

De Berardis, Giorgia, et al. “Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): Design of a Randomized Study of the Efficacy of Low-Dose Aspirin in the Prevention of Cardiovascular Events in Subjects with Diabetes Mellitus Treated with Statins.” Trials, vol. 8, Aug. 2007, p. 21. EBSCOhost, https://doi.org/10.1186/1745-6215-8-21.

APA

De Berardis, G., Sacco, M., Evangelista, V., Filippi, A., Giorda, C. B., Tognoni, G., Valentini, U., & Nicolucci, A. (2007). Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials, 8, 21. https://doi.org/10.1186/1745-6215-8-21

Chicago

De Berardis, Giorgia, Michele Sacco, Virgilio Evangelista, Alessandro Filippi, Carlo B Giorda, Gianni Tognoni, Umberto Valentini, and Antonio Nicolucci. 2007. “Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): Design of a Randomized Study of the Efficacy of Low-Dose Aspirin in the Prevention of Cardiovascular Events in Subjects with Diabetes Mellitus Treated with Statins.” Trials 8 (August): 21. doi:10.1186/1745-6215-8-21.